2024 Q1 Form 10-Q Financial Statement

#000121390024043817 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $30.00K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $700.2K $386.8K
YoY Change 81.02% 32132.5%
Operating Profit -$700.2K -$386.8K
YoY Change 81.02% 32132.58%
Interest Expense $372.7K $838.6K
YoY Change -55.56%
% of Operating Profit
Other Income/Expense, Net $372.7K $838.6K
YoY Change -55.57%
Pretax Income -$327.5K $451.9K
YoY Change -172.48% -37754.17%
Income Tax
% Of Pretax Income
Net Earnings -$327.5K $451.9K
YoY Change -172.48% -37754.33%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.07 $0.10
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $316.0K $81.95M
YoY Change -99.61% 1655496.77%
Cash & Equivalents $316.0K $54.46K
Short-Term Investments
Other Short-Term Assets $74.29K $80.63K
YoY Change -7.86% -65.33%
Inventory
Prepaid Expenses $74.29K $80.63K
Receivables
Other Receivables
Total Short-Term Assets $390.3K $82.03M
YoY Change -99.52% 34438.61%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $29.11M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $29.11M $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $390.3K $82.03M
Total Long-Term Assets $29.11M $0.00
Total Assets $29.50M $82.03M
YoY Change -64.04% 34438.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $214.9K
YoY Change
Accrued Expenses $1.121M $979.2K
YoY Change 14.52% 3633.04%
Deferred Revenue
YoY Change
Short-Term Debt $900.0K $530.0K
YoY Change 69.81% 175.74%
Long-Term Debt Due $2.298M
YoY Change
Total Short-Term Liabilities $4.534M $3.872M
YoY Change 17.11% 1672.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.363M
YoY Change
Total Long-Term Liabilities $2.363M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.534M $3.872M
Total Long-Term Liabilities $2.363M $0.00
Total Liabilities $6.896M $3.872M
YoY Change 78.13% 1672.42%
SHAREHOLDERS EQUITY
Retained Earnings -$6.506M -$3.737M
YoY Change 74.11%
Common Stock $209.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.506M -$3.737M
YoY Change
Total Liabilities & Shareholders Equity $29.50M $82.03M
YoY Change -64.04% 34438.61%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$327.5K $451.9K
YoY Change -172.48% -37754.33%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$582.4K -$407.3K
YoY Change 43.0% 203526.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$225.0K
YoY Change
Cash From Investing Activities -$225.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.066M $50.00K
YoY Change 2032.26% 870.87%
NET CHANGE
Cash From Operating Activities -$582.4K -$407.3K
Cash From Investing Activities -$225.0K
Cash From Financing Activities $1.066M $50.00K
Net Change In Cash $258.7K -$357.3K
YoY Change -172.42% -7317.23%
FREE CASH FLOW
Cash From Operating Activities -$582.4K -$407.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2024Q1 dei Entity Address Country
EntityAddressCountry
GB
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-41363
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
25 Bedford Square
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
London
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
WC1B 3HH
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
true
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
316030 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57290 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
74287 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
412 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
390317 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
57702 usd
CY2024Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
29105841 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
28508214 usd
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
29105841 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
28508214 usd
CY2024Q1 us-gaap Assets
Assets
29496158 usd
CY2023Q4 us-gaap Assets
Assets
28565916 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1121341 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
959720 usd
CY2024Q1 clcr Notes Payable Current Administrative Service
NotesPayableCurrentAdministrativeService
214941 usd
CY2023Q4 clcr Notes Payable Current Administrative Service
NotesPayableCurrentAdministrativeService
184941 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4533938 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3226185 usd
CY2024Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2362500 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2362500 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2362500 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2412500 usd
CY2024Q1 us-gaap Liabilities
Liabilities
6896438 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5638685 usd
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
29105841 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
28508214 usd
CY2024Q1 clcr Total Commitment And Contingencies
TotalCommitmentAndContingencies
29105841 usd
CY2023Q4 clcr Total Commitment And Contingencies
TotalCommitmentAndContingencies
28508214 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6506330 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5581192 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6506121 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5580983 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29496158 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28565916 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
670161 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
356791 usd
CY2024Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 usd
CY2023Q1 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-700161 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-386791 usd
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
23 usd
CY2024Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
372627 usd
CY2023Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
858477 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-19834 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
372650 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
838643 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-327511 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
451852 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5580983 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-597627 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-327511 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-6506121 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3329967 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-858477 usd
CY2023Q1 clcr Conversion Of Shares
ConversionOfShares
1968749 shares
CY2023Q1 clcr Conversion Price Par Value
ConversionPriceParValue
0.0001
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
451852 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3736592 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-327511 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
451852 usd
CY2024Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
372627 usd
CY2023Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
858477 usd
CY2023Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
19834 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
161621 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-71079 usd
CY2024Q1 clcr Increase Decrease In Administrative Service Fee Payable Related Party
IncreaseDecreaseInAdministrativeServiceFeePayableRelatedParty
30000 usd
CY2023Q1 clcr Increase Decrease In Administrative Service Fee Payable Related Party
IncreaseDecreaseInAdministrativeServiceFeePayableRelatedParty
24701 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
73875 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-25916 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-582392 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-407253 usd
CY2024Q1 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
225000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-225000 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
766132 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
50000 usd
CY2024Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
300000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1066132 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
258740 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-357253 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57290 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411711 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
316030 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54458 usd
CY2024Q1 clcr Remeasurement Adjustment On Public Shares Subject To Possible Redemption
RemeasurementAdjustmentOnPublicSharesSubjectToPossibleRedemption
597627 usd
CY2024Q1 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
1181250 usd
CY2024Q1 us-gaap Payments For Commissions
PaymentsForCommissions
2362500 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
604011 usd
CY2024Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
79931250 usd
CY2024Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
316030 usd
CY2024Q1 clcr Assets Held In Trust Account
AssetsHeldInTrustAccount
0.80 pure
CY2024Q1 clcr Interest Earned On The Funds Held In The Trust Account
InterestEarnedOnTheFundsHeldInTheTrustAccount
11.29
CY2024Q1 us-gaap Deposits
Deposits
787500 usd
CY2024Q1 clcr Deposits Per Share
DepositsPerShare
0.1
CY2023Q2 clcr Sponsor Loan
SponsorLoan
75000 usd
CY2024Q1 us-gaap Cash
Cash
316030 usd
CY2024Q1 clcr Working Capital Deficit
WorkingCapitalDeficit
4143621 usd
CY2024Q1 us-gaap Fiscal Period
FiscalPeriod
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prior period reclassifications</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To conform with the current period presentation, management has reclassified a portion of the amount previously presented within “Formation and operating costs” on the statement of operations for the quarter ended March 31, 2023, and “Accrued liabilities, excluding unrealized foreign exchange loss” on the statement of cash flows for the quarter ended March 31, 2023 to report “Administrative service fees - related party” and “Administrative service fee payable - related party”, respectively.</p>
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
316030 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57290 usd
CY2024Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
29105841 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
28508214 usd
CY2024Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
372627 usd
CY2023Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
858477 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-327511 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
451852 usd
CY2024Q1 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
225000 usd
CY2024Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
372627 usd
CY2023Q1 us-gaap Investment Income Dividend
InvestmentIncomeDividend
858477 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
925138 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
406625 usd
CY2024Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
78750000 usd
CY2023Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
78750000 usd
CY2024Q1 clcr Proceeds Allocated To Public Warrants And Public Rights
ProceedsAllocatedToPublicWarrantsAndPublicRights
6898500 usd
CY2023Q4 clcr Proceeds Allocated To Public Warrants And Public Rights
ProceedsAllocatedToPublicWarrantsAndPublicRights
6898500 usd
CY2024Q1 clcr Reclassification Of Offering Costs Related To Public Shares
ReclassificationOfOfferingCostsRelatedToPublicShares
4647702 usd
CY2023Q4 clcr Reclassification Of Offering Costs Related To Public Shares
ReclassificationOfOfferingCostsRelatedToPublicShares
4647702 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
55265334 usd
CY2023Q4 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
55265334 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
16342377 usd
CY2023Q4 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
15969750 usd
CY2024Q1 clcr Monthly Extension Fees
MonthlyExtensionFees
825000 usd
CY2023Q4 clcr Monthly Extension Fees
MonthlyExtensionFees
600000 usd
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
29105841 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
28508214 usd
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
375000 shares
CY2022Q2 clcr Founder Shares Were No Longer Subject To Forfeiture
FounderSharesWereNoLongerSubjectToForfeiture
93750 shares
CY2022Q2 clcr Number Of Shares Subject To Forfeiture
NumberOfSharesSubjectToForfeiture
187500 shares
CY2024Q1 clcr Due To Affiliate
DueToAffiliate
170603 usd
CY2023Q4 clcr Due To Affiliate
DueToAffiliate
170603 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
300000 usd
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
50000 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
150000 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
125000 usd
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
125000 usd
CY2023Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
100000 usd
CY2024Q1 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
653619 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
335000 usd
CY2023Q4 us-gaap Investment Interest Rate Paid In Cash
InvestmentInterestRatePaidInCash
0.05 pure
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
788434 usd
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
22302 usd
CY2023Q4 us-gaap Other Loans Payable
OtherLoansPayable
357302 usd
CY2023Q4 clcr Interest Rate Percentage
InterestRatePercentage
0.05 pure
CY2023Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
900000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
75000 usd
CY2023Q2 clcr Interest Rate Percentage
InterestRatePercentage
0.05 pure
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
CY2024Q1 us-gaap Product Liability Contingency Loss Exposure Not Accrued Best Estimate
ProductLiabilityContingencyLossExposureNotAccruedBestEstimate
900000 usd
CY2023 us-gaap Product Liability Contingency Loss Exposure Not Accrued Best Estimate
ProductLiabilityContingencyLossExposureNotAccruedBestEstimate
600000 usd
CY2024Q1 clcr Notes Payable Current Administrative Service
NotesPayableCurrentAdministrativeService
214941 usd
CY2023Q4 clcr Notes Payable Current Administrative Service
NotesPayableCurrentAdministrativeService
184941 usd
CY2022Q3 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
500000 usd
CY2022Q3 clcr Purchase Price
PurchasePrice
400000000 usd
CY2022Q3 clcr Total Remuneration Transaction Price
TotalRemunerationTransactionPrice
400000001 usd
CY2022Q3 clcr Transactions Purchase Price
TransactionsPurchasePrice
1000000 usd
CY2022Q4 us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
250000 usd
CY2022Q4 us-gaap Additional Collateral Aggregate Fair Value
AdditionalCollateralAggregateFairValue
400000000 usd
CY2024Q1 clcr Cash Fee Payable Percentage
CashFeePayablePercentage
0.02 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
375000 shares
CY2024Q1 us-gaap Other Underwriting Expense
OtherUnderwritingExpense
0.45 usd
CY2024Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
125000 usd
CY2024Q1 clcr Upfront Retainer Amount
UpfrontRetainerAmount
37500 usd
CY2024Q1 clcr Billed Balance Percentage
BilledBalancePercentage
0.50 pure
CY2024Q1 clcr Outstanding Balance Percentage
OutstandingBalancePercentage
0.50 pure
CY2024Q1 clcr Initial Business Combination Paid Percentage
InitialBusinessCombinationPaidPercentage
0.20 pure
CY2024Q1 clcr Outstanding Billed Amount For Services Provided
OutstandingBilledAmountForServicesProvided
895679 usd
CY2023 clcr Outstanding Billed Amount For Services Provided
OutstandingBilledAmountForServicesProvided
892784 usd
CY2024Q1 clcr Outstanding Balance Amount
OutstandingBalanceAmount
447840 usd
CY2023 clcr Outstanding Balance Amount
OutstandingBalanceAmount
446392 usd
CY2023 clcr Outstanding Balance Percentage
OutstandingBalancePercentage
0.50 pure
CY2023Q1 clcr Gross Proceeds Received Percentage
GrossProceedsReceivedPercentage
0.01 pure
CY2022Q3 us-gaap Principal Transactions Revenue
PrincipalTransactionsRevenue
50000000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
150000 usd
CY2022Q3 us-gaap Payments For Fees
PaymentsForFees
40000000 usd
CY2022Q3 clcr Transaction Success Fee
TransactionSuccessFee
500000 usd
CY2022Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
15000 usd
CY2022Q3 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
20000 usd
CY2022Q3 clcr Aggregate Transaction Value
AggregateTransactionValue
400000000 usd
CY2022Q3 clcr Retainer Fees
RetainerFees
40000 usd
CY2024Q1 clcr Transactions Payable
TransactionsPayable
1600000 usd
CY2024Q1 clcr Transactions Behalf Payable
TransactionsBehalfPayable
1600000 usd
CY2024Q1 clcr Aggregate Transaction Value
AggregateTransactionValue
300000000 usd
CY2024Q1 clcr Transaction Purchase Price
TransactionPurchasePrice
0.0085 pure
CY2024Q1 us-gaap Fair Value Option Aggregate Differences Long Term Debt Instruments
FairValueOptionAggregateDifferencesLongTermDebtInstruments
300000000 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.004 pure
CY2024Q1 clcr Transaction Success Fee
TransactionSuccessFee
1000000 eur
CY2024Q1 us-gaap Subsequent Event Effect Of Change In Tax Status
SubsequentEventEffectOfChangeInTaxStatus
120000 usd
CY2024Q1 us-gaap Other Payments To Acquire Businesses
OtherPaymentsToAcquireBusinesses
650000000 usd
CY2024Q1 clcr Shares Based On The Achievement Amount
SharesBasedOnTheAchievementAmount
150000000 usd
CY2024Q1 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
52000000 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 clcr Redemption Price Per Warrant
RedemptionPricePerWarrant
0.01
CY2024Q1 clcr Number Of Days For Written Notice Of Redemption
NumberOfDaysForWrittenNoticeOfRedemption
P30D
CY2024Q1 clcr Minimum Threshold Price Of Common Stock Specified To Send Notice Of Redemption To The Warrant Holders
MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders
18
CY2024Q1 clcr Common Stock Threshold Trading Days
CommonStockThresholdTradingDays
20 pure
CY2024Q1 clcr Common Stock Threshold Consecutive Trading Days
CommonStockThresholdConsecutiveTradingDays
30 pure
CY2024Q1 clcr Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price
PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice
9.2
CY2024Q1 clcr Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price Percentage Of Equity Proceeds From Issuance
PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPricePercentageOfEquityProceedsFromIssuance
0.60 pure
CY2024Q1 clcr Percentage Of Warrant Exercise Price Adjusted To Price Received In New Issuance
PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance
1.15 pure
CY2024Q1 clcr Class Of Warrant Or Right Target Share Price Of Warrants Or Rights For Redemption
ClassOfWarrantOrRightTargetSharePriceOfWarrantsOrRightsForRedemption
18
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2024Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
usd
CY2023Q1 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 clcr Remeasurement Adjustment On Public Shares Subject To Possible Redemption
RemeasurementAdjustmentOnPublicSharesSubjectToPossibleRedemption
usd
CY2023Q1 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei City Area Code
CityAreaCode
+44
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001903392

Files In Submission

Name View Source Status
0001213900-24-043817-index-headers.html Edgar Link pending
0001213900-24-043817-index.html Edgar Link pending
0001213900-24-043817.txt Edgar Link pending
0001213900-24-043817-xbrl.zip Edgar Link pending
clcr-20240331.xsd Edgar Link pending
ea0206007-10q_climate.htm Edgar Link pending
ea020600701ex10-4_climate.htm Edgar Link pending
ea020600701ex31-1_climate.htm Edgar Link pending
ea020600701ex31-2_climate.htm Edgar Link pending
ea020600701ex32-1_climate.htm Edgar Link pending
ea020600701ex32-2_climate.htm Edgar Link pending
ex10-4_001.jpg Edgar Link pending
ex10-4_002.jpg Edgar Link pending
ex10-4_003.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
clcr-20240331_cal.xml Edgar Link unprocessable
clcr-20240331_def.xml Edgar Link unprocessable
clcr-20240331_lab.xml Edgar Link unprocessable
clcr-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0206007-10q_climate_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending